Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-05 Sale | 2024-09-05 7:48 pm | Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL | 2,525 | $0.566 | $1,429 | 51,927 (Direct) | View |
| 2024-01-05 Sale(A) | 2024-02-16 4:37 pm | Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL | 2,412 | $2.91 | $7,019 | 34,452 (Direct) | View |
| 2024-01-05 Sale | 2024-01-08 4:38 pm | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel | 2,412 | $2.91 | $7,019 | 34,452 (Direct) | View |
| 2022-06-23 Sale | 2022-06-24 7:55 pm | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel | 2,614 | $2.69 | $7,032 | 19,097 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-01 Option Award | 2024-10-03 7:08 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO | 220,000 | $0 | 220,000 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-05 7:48 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL | 10,000 | $0 | 51,927 (Direct) | View |
| 2024-05-20 Option Award | 2024-09-05 7:48 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL | 10,000 | $1.34 | 51,927 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 5:01 pm | N/A 2034-02-13 | Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL | 220,000 | $0 | 220,000 (Direct) | View |
| 2023-05-18 Option Award(A) | 2024-02-16 4:37 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL | 7,767 | $2.41 | 34,452 (Direct) | View |
| 2024-01-04 Option Award(A) | 2024-02-16 4:37 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL | 10,000 | $0 | 34,452 (Direct) | View |
| 2023-05-18 Option Award | 2024-01-08 4:38 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel | 7,767 | $2.41 | 34,452 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 4:38 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel | 10,000 | $0 | 34,452 (Direct) | View |
| 2023-01-19 Option Award | 2023-01-23 5:55 pm | N/A 2033-01-18 | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 7:55 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel | 10,000 | $0 | 19,097 (Direct) | View |
| 2022-05-18 Option Award | 2022-06-24 7:55 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel | 3,396 | $7.06 | 19,097 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 5:27 pm | N/A 2032-01-17 | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel | 150,000 | $0 | 150,000 (Direct) | View |
| 2021-11-03 Option Award | 2021-11-05 5:03 pm | N/A 2031-11-02 | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel | 150,000 | $0 | 150,000 (Direct) | View |
Ownership | 2021-06-01 6:32 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel | 0 | $0 | 8,315 (Direct) | View |